ArticleNaunyn-Schmiedeberg's archives of pharmacology2017

Interleukin-19 contributes as a protective factor in experimental Th2-mediated colitis.

Yasuyuki Fujimoto et al.PubMed ↗Publisher ↗

No numbers read from the abstract.